Insider Trading Alert - SFM, PF And RMD Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Dec. 1, 2014, 117 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $311.47 to $11,658,664.23.

Highlighted Stocks Traded by Insiders:

Sprouts Farmers Market (SFM) - FREE Research Report

Fortunato Joe, who is Director at Sprouts Farmers Market, sold 15,000 shares at $32.11 on Dec. 1, 2014. Following this transaction, the Director owned 27,500 shares meaning that the stake was reduced by 35.29% with the 15,000-share transaction.

The shares most recently traded at $32.00, down $0.11, or 0.36% since the insider transaction.

The average volume for Sprouts Farmers Market has been 1.1 million shares per day over the past 30 days. Sprouts Farmers Market has a market cap of $4.8 billion and is part of the services sector and retail industry. Shares are down 17.28% year-to-date as of the close of trading on Friday.

Sprouts Farmers Market, Inc., through its subsidiaries, is engaged in the retail of natural and organic food in the United States. The company has a P/E ratio of 49.6. Currently, there are 5 analysts who rate Sprouts Farmers Market a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SFM - FREE

TheStreet Quant Ratings rates Sprouts Farmers Market as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity and impressive record of earnings per share growth. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, premium valuation and weak operating cash flow. Get the full Sprouts Farmers Market Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Pinnacle Foods (PF) - FREE Research Report

Kroeger John F., who is Svp, Dgc, As at Pinnacle Foods, sold 350 shares at $33.36 on Dec. 1, 2014. Following this transaction, the Svp, Dgc, As owned 49,437 shares meaning that the stake was reduced by 0.7% with the 350-share transaction.

The shares most recently traded at $33.95, up $0.59, or 1.74% since the insider transaction. Historical insider transactions for Pinnacle Foods go as follows:

  • 4-Week # shares bought: 6,500
  • 4-Week # shares sold: 153,035
  • 12-Week # shares bought: 6,500
  • 12-Week # shares sold: 169,805
  • 24-Week # shares bought: 6,500
  • 24-Week # shares sold: 227,016

The average volume for Pinnacle Foods has been 1.2 million shares per day over the past 30 days. Pinnacle Foods has a market cap of $3.9 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 23.93% year-to-date as of the close of trading on Friday.

Pinnacle Foods Inc., through its subsidiaries, manufactures, markets, and distributes branded convenience food products in North America. It operates through three segments: Birds Eye Frozen, Duncan Hines Grocery, and Specialty Foods. The stock currently has a dividend yield of 2.81%. The company has a P/E ratio of 14.4. Currently, there are 6 analysts who rate Pinnacle Foods a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PF - FREE

TheStreet Quant Ratings rates Pinnacle Foods as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and impressive record of earnings per share growth. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk and poor profit margins. Get the full Pinnacle Foods Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

ResMed (RMD) - FREE Research Report

Sandercock Brett, who is Chief Financial Officer at ResMed, sold 15,000 shares at $51.15 on Dec. 1, 2014. Following this transaction, the Chief Financial Officer owned 79,583 shares meaning that the stake was reduced by 15.86% with the 15,000-share transaction.

The shares most recently traded at $53.29, up $2.14, or 4.02% since the insider transaction. Historical insider transactions for ResMed go as follows:

  • 4-Week # shares sold: 29,047
  • 12-Week # shares sold: 29,047
  • 24-Week # shares sold: 49,047

The average volume for ResMed has been 985,000 shares per day over the past 30 days. ResMed has a market cap of $7.5 billion and is part of the health care sector and health services industry. Shares are up 13% year-to-date as of the close of trading on Friday.

ResMed Inc. develops, manufactures, distributes, and markets medical equipment for the diagnosis, treatment, and management of respiratory disorders, with a focus on sleep-disordered breathing. The stock currently has a dividend yield of 2.09%. The company has a P/E ratio of 22.3. Currently, there are 4 analysts who rate ResMed a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RMD - FREE

TheStreet Quant Ratings rates ResMed as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full ResMed Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Boeing Is Back to Cruising Altitude; GM Gets Assist From Amazon -- ICYMI

Boeing Is Back to Cruising Altitude; GM Gets Assist From Amazon -- ICYMI

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

Aceto's Search for Deal May Be Slowed by DOJ Subpoena

Aceto's Search for Deal May Be Slowed by DOJ Subpoena

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk